BCL-2 in prostate cancer: A minireview

@article{Catz2004BCL2IP,
  title={BCL-2 in prostate cancer: A minireview},
  author={S. Catz and J. Johnson},
  journal={Apoptosis},
  year={2004},
  volume={8},
  pages={29-37}
}
Prostate cancer progression and the development of androgen-independent prostate cancer have been largely related to a number of genetic abnormality that affect not only the androgen receptor but also crucial molecules involved in the regulation of survival or apoptotic pathways. One of these molecules, the pro-survival protein BCL-2, has been associated with the development of androgen-independent prostate cancer due to its high levels of expression in androgen-independent tumors in advanced… Expand
Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage
TLDR
It is reported that Bcl-2 is required for the progression of LNCaP prostate cancer cells from an androgens-dependent to an androgen-independent growth stage and shRNA-mediated gene silencing of Bcl1 promotes UV-induced apoptosis and suppresses the growth of prostate tumors in vivo. Expand
Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression
TLDR
To identify more effective prostate cancer therapy, further mechanistic studies are required with BCL-2 inhibitors in AIPC and ADPC, considering a multi-target therapy against BCL -2 and its related signaling. Expand
SRC-3 is required for prostate cancer cell proliferation and survival.
TLDR
It is demonstrated that reduction of SRC-3 expression by small interfering RNA decreases proliferation, delays the G1-S transition, and increases cell apoptosis of different prostate cancer cell lines, and findings indicate that S RC-3 is an important regulator of prostate cancer proliferation and survival. Expand
Death receptor‐induced cell death in prostate cancer
TLDR
This review has focused on what is known about apoptosis in prostate cancer and, more specifically, the receptor/ligand‐mediated pathways of apoptosis as potential therapeutic targets. Expand
Prostate Cancer: A Continuous Evolutionary Search for Molecular Therapy Targets
  • 2019
Prostate Cancer (PCa) is the malignant neoplasia that develops in the prostate gland of a male reproductive system. It's clear causes are unknown, but it usually results from alterations in cellularExpand
Signaling Pathways That Control Apoptosis in Prostate Cancer
TLDR
Better knowledge of the apoptosis regulation in prostate epithelial cells is needed to understand mechanisms of androgen-independence and implement life-extending therapies for CRPC. Expand
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
TLDR
The results strongly support a role for bcl-2, COX-2 and angiogenesis in the development and progression of prostate cancer. Expand
Molecular mechanisms of apoptosis in prostate cancer.
TLDR
The most important signaling pathways implicated in prostate cancer apoptosis and cell growth and how they may be deregulated during prostate cancer progression are reviewed. Expand
Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression
TLDR
It was concluded that quercetin inhibits prostate cancer cell proliferation by altering the expression of cell cycle regulators and apoptotic proteins. Expand
Inflammation and Prostatic Carcinogenesis - a morphological study of the human prostate
TLDR
This study provides the first evidence of a direct link between COX-2 and angiogenesis in PCa tissues and demonstrates that chronic inflammation appeared to play a role in inducing C/EBPβ expression in atrophic prostate epithelial cells. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 115 REFERENCES
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
TLDR
It is indicated that bcl-2 expression is augmented following androgen ablation and is correlated with the progression of prostate cancer from androgen dependence to androgen independence. Expand
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
TLDR
Data obtained in this study demonstrate that the bcl-2 oncoprotein can protect prostate cancer cells from apoptotic stimuli in vitro and suggest that such protection correlates with the ability to form hormone-refractory prostate tumors in vivo. Expand
Expression of bcl-2 and the progression of human and rodent prostatic cancers.
TLDR
The data demonstrate that the development of androgen independence and/or metastatic ability can be associated with the expression of bcl-2 protein but that b cl-2-independent mechanisms also exist for such progression. Expand
Antagonism between PTEN/MMAC1/TEP-1 and Androgen Receptor in Growth and Apoptosis of Prostatic Cancer Cells*
TLDR
The data suggest that the loss of PTEN function may induce tumorigenesis through unopposed activity of the AR as well as contribute to the resistance of prostate cancers to androgen ablation therapy. Expand
PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression*
TLDR
It is demonstrated that expression of Bcl-2 in prostate tumors correlates with loss of the PTEN protein, thus contributing to survival and chemoresistance of PCa cells and suggesting that thePTEN gene and its regulated pathway are potential therapeutic targets in prostate cancer. Expand
The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.
  • K. Fizazi, L. A. Martinez, +9 authors N. Navone
  • Biology, Medicine
  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2002
TLDR
Tumor relapse, defining AIPC, was associated with increased expression of p21 to levels comparable with those found before castration, and p21 expression at relapse was also correlated with a high Ki-67 index. Expand
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
TLDR
It is suggested that expression of several anti-apoptotic members of the bcl-2 gene family, including b cl-2, bcl -X, and mcl-1 increases during progression of prostate cancers, a finding that may be relevant to the hormone-insensitive, metastatic phenotype of most advanced adenocarcinomas of the prostate. Expand
Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer
TLDR
The results suggest that treatment of prostate cancer patients with suramin prior to irradiation is likely to inhibit radiation palliation, and that radiation therapy followed by suramin treatment may yield enhanced effectiveness. Expand
Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells.
TLDR
It is indicated that androgens can down-regulate bcl-2 protooncogene levels via an androgen receptor-mediated mechanism, thus providing a novel mechanism for their known inhibitory effect on breast cancer cell growth. Expand
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
TLDR
Data show that androgen ablation alone can increase PI3K-Akt activation, which supports survival after acute androgens ablation and proliferation during chronic androgen deprivation, and successful progression to the androgen-independent state in the LNCaP cell line model requires intact PI3k signaling. Expand
...
1
2
3
4
5
...